﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xsi:schemaLocation="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2017v2.3">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2018-12-19T13:09:36-06:00</ReturnTs>
    <TaxPeriodEndDt>2018-06-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmName>
        <BusinessNameLine1Txt>KPMG LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>345 PARK AVE</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10154</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2017-07-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>231907729</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>JDRF INTERNATIONAL</BusinessNameLine1Txt>
      </BusinessName>
      <InCareOfNm>% GARY CURTO C/O JDRF INT</InCareOfNm>
      <BusinessNameControlTxt>JDRF</BusinessNameControlTxt>
      <PhoneNum>2127859500</PhoneNum>
      <USAddress>
        <AddressLine1Txt>26 BROADWAY 15TH FL</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10004</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>JOANNE MARTZ</PersonNm>
      <PersonTitleTxt>CFO</PersonTitleTxt>
      <SignatureDt>2018-12-19</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>NICOLE FITZMAURICE</PreparerPersonNm>
      <PTIN>P01491005</PTIN>
      <PhoneNum>2127859700</PhoneNum>
    </PreparerPersonGrp>
    <FilingSecurityInformation>
      <IPAddress>
        <IPv4AddressTxt>38.126.140.251</IPv4AddressTxt>
      </IPAddress>
      <FederalOriginalSubmissionId>20543020183535000000</FederalOriginalSubmissionId>
      <FederalOriginalSubmissionIdDt>2018-12-19</FederalOriginalSubmissionIdDt>
      <FilingLicenseTypeCd>P</FilingLicenseTypeCd>
      <AtSubmissionCreationDeviceId>77CC1D621559563551A28EC037FDBF081FD11258</AtSubmissionCreationDeviceId>
      <AtSubmissionFilingDeviceId>EE4E115A3C9DFA99524036053EAAB45418171949</AtSubmissionFilingDeviceId>
    </FilingSecurityInformation>
    <TaxYr>2017</TaxYr>
    <BuildTS>2019-02-21 02:37:17Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="13">
    <IRS990 documentId="IRS990" referenceDocumentId="IRS990ScheduleO">
      <PrincipalOfficerNm>DEREK RAPP</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>26 BROADWAY 14TH FLOOR</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10004</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>260616536</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>www.jdrf.org</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1970</FormationYr>
      <LegalDomicileStateCd>PA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>THE MISSION OF JDRF IS TO ACCELERATE BREAKTHROUGHS TO CURE, PREVENT AND TREAT TYPE I DIABETES. SEE SCHEDULE O</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>34</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>33</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>886</TotalEmployeeCnt>
      <TotalVolunteersCnt>249300</TotalVolunteersCnt>
      <TotalGrossUBIAmt>17064</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>39647</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>199896852</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>219968105</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>0</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>1227269</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>7177001</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>1129676</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>2970878</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>202253797</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>230115984</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>79009656</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>84651980</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>75347284</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>81433187</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>2328</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>27984238</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>39432392</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>42340180</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>193789332</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>208427675</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>8464465</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>21688309</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>198753573</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>226353181</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>121385069</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>129947696</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>77368504</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>96405485</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>At JDRF, we work tirelessly to accelerate breakthroughs to cure, prevent and treat type 1 diabetes (T1D). We continually expand our scientific knowledge, our connections and collaborations, our partners and global presence to unlock the science that will stop T1D. While we fight for a cure, we strive just as hard to develop therapies to help people right now. JDRF and our scientists are leading T1D research around the world. We address key gaps to move research faster and farther across the development pipeline and to translate breakthroughs into new therapies for people with T1D. This enables us to advance science with the most potential and to drive research that attracts more resources and scientific expertise to the field. We invest in the early stages, allowing researchers to pursue innovative ideas and approaches that will lead to breakthrough treatments. JDRF also works to drive new therapies and technologies to market so they get into the hands of people with T1D more quickly.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>84651980</ExpenseAmt>
      <GrantAmt>84651980</GrantAmt>
      <Desc>RESEARCH FUNDING - FOR THE FY18 PERIOD ENDING JUNE 30, 2018, JDRF DIRECTLY FUNDED RESEARCH GRANTS AND INDUSTRY AGREEMENTS FOR WHICH $85 MILLION IN RESEARCH GRANT NET EXPENSE WAS RECOGNIZED ACCORDING TO GAAP AND EXCLUDING $11.3 MILLION OF PROGRAMMATIC RESEARCH INVESTMENTS WHICH ARE RECORDED TO THE ORGANIZATION'S BALANCE SHEET. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO DIRECT RESEARCH FUNDING. SEE SCHEDULE O.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>23138667</ExpenseAmt>
        <Desc>RESEARCH SUPPORT - JDRF MAINTAINS AN IN-HOUSE TEAM OF SKILLED SCIENTIFIC, MEDICAL, POLICY AND GOVERNMENT RELATIONS PROFESSIONALS WHO PLAY A CRITICAL ROLE IN LEADING AND SUPPORTING THE EVALUATION OF RESEARCH FUNDING OPPORTUNITIES BY JDRF AND INFLUENCING RESEARCH DIRECTION AND THE DISBURSEMENT OF RESEARCH FUNDS FROM OTHERS. THESE PROFESSIONALS ALSO WORK WITH REGULATORY AND POLICY OFFICIALS TO ENSURE THAT RESEARCH CAN PROCEED WITHOUT DELAY AND RESULTS ARE UNDERSTOOD BY HEALTHCARE DECISION MAKERS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO RESEARCH SUPPORT. SEE SCHEDULE O.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>56283982</ExpenseAmt>
        <Desc>PUBLIC EDUCATION AND OUTREACH - JDRF EDUCATES THE COMMUNITY AND PROVIDES OUTREACH SERVICES TO NEWLY DIAGNOSED CHILDREN AND ADULTS, THEIR FAMILIES AND OTHERS ABOUT T1D AND ITS COMPLICATIONS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO PUBLIC EDUCATION AND OUTREACH. SEE SCHEDULE O.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>164074629</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="IRS990ScheduleA">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="IRS990ScheduleB">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd referenceDocumentId="IRS990ScheduleC">false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd referenceDocumentId="IRS990ScheduleC">true</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd referenceDocumentId="IRS990ScheduleC">false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="IRS990ScheduleD">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="IRS990ScheduleD">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="IRS990ScheduleD">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="IRS990ScheduleD">false</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="IRS990ScheduleD">true</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="IRS990ScheduleD">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="IRS990ScheduleD">true</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="IRS990ScheduleD">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="IRS990ScheduleD">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="IRS990ScheduleD">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="IRS990ScheduleD">true</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>true</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="IRS990ScheduleF">true</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="IRS990ScheduleF">true</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="IRS990ScheduleF">false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="IRS990ScheduleG">true</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="IRS990ScheduleG">true</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="IRS990ScheduleG">true</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="IRS990ScheduleI">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="IRS990ScheduleI">false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="IRS990ScheduleJ">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="IRS990ScheduleL">false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="IRS990ScheduleL">false</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="IRS990ScheduleL">false</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="IRS990ScheduleL">false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="IRS990ScheduleL">false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="IRS990ScheduleL">true</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd referenceDocumentId="IRS990ScheduleL">false</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd referenceDocumentId="IRS990ScheduleM">true</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd referenceDocumentId="IRS990ScheduleM">false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="IRS990ScheduleR">true</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="IRS990ScheduleR">true</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>true</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd referenceDocumentId="IRS990ScheduleR">false</TransactionWithControlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="IRS990ScheduleR">false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="IRS990ScheduleR">false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <InfoInScheduleOPartVInd>X</InfoInScheduleOPartVInd>
      <IRPDocumentCnt>1044</IRPDocumentCnt>
      <IRPDocumentW2GCnt>5</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>886</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>true</UnrelatedBusIncmOverLimitInd>
      <Form990TFiledInd>true</Form990TFiledInd>
      <ForeignFinancialAccountInd>true</ForeignFinancialAccountInd>
      <ForeignCountryCd>IS</ForeignCountryCd>
      <ForeignCountryCd>DA</ForeignCountryCd>
      <ForeignCountryCd>NL</ForeignCountryCd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>true</QuidProQuoContributionsInd>
      <QuidProQuoContriDisclInd>true</QuidProQuoContriDisclInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <Form1098CFiledInd>true</Form1098CFiledInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>34</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>33</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>true</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>true</LocalChaptersInd>
      <PoliciesReferenceChaptersInd>true</PoliciesReferenceChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>true</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>true</InvestmentInJointVentureInd>
      <WrittenPolicyOrProcedureInd>true</WrittenPolicyOrProcedureInd>
      <StatesWhereCopyOfReturnIsFldCd>AL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>AK</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>AZ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>AR</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CO</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>DE</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>DC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>FL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>GA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>HI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>ID</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>KS</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>KY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>LA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>ME</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MS</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MO</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NE</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NV</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NM</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>ND</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OK</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OR</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>RI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>SC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>SD</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>TN</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>TX</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>UT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VT</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WV</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WY</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>GARY CURTO CO JDRF INT</PersonNm>
        <PhoneNum>2124797551</PhoneNum>
        <USAddress>
          <AddressLine1Txt>26 BROADWAY 1TH FL</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10004</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>MIKE LEE FY16-18</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LARRY SOLER FY16-18</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>WENDY WOOD FY16-18</PersonNm>
        <TitleTxt>CHAIR, INVESTMENT</TitleTxt>
        <AverageHoursPerWeekRt>10.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NANETTE DETURK FY17-19</PersonNm>
        <TitleTxt>CHAIR, ADVOCACY</TitleTxt>
        <AverageHoursPerWeekRt>5.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MICHELLE GRIFFIN FY17-19</PersonNm>
        <TitleTxt>CHAIR, DEVELOPMENT</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>STEPHEN NEWMAN MD FY17-19</PersonNm>
        <TitleTxt>CHAIR, RESEARCH</TitleTxt>
        <AverageHoursPerWeekRt>5.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RANDY ANDERSON FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>TIMOTHY CLARK FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARK FISCHER-COLBRIE FY16-18</PersonNm>
        <TitleTxt>CHAIRMAN OF THE BOARD</TitleTxt>
        <AverageHoursPerWeekRt>20.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LISA REED FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARVIN DAITCH FY16-18</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PAM EDMONDS FY16-18</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JEFF PLUMER FY16-18</PersonNm>
        <TitleTxt>CHAIR, AUDIT</TitleTxt>
        <AverageHoursPerWeekRt>5.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LISA WALLACK FY16-18</PersonNm>
        <TitleTxt>SECRETARY, CHAIR NOMINATING</TitleTxt>
        <AverageHoursPerWeekRt>5.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SEAN DOHERTY FY17-19</PersonNm>
        <TitleTxt>CHAIR, JDRF T1D FUND LLC</TitleTxt>
        <AverageHoursPerWeekRt>5.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PAUL HEATH FY17-19</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KAREN JORDAN FY17-19</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN KAMPFE FY17-19</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ELLEN LEAKE FY17-19</PersonNm>
        <TitleTxt>BOARD VICE-CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>10.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DOUG LOWENSTEIN FY17-19</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DAYTON OGDEN FY17-19</PersonNm>
        <TitleTxt>CHAIR, TALENT &amp; COMPENSATION</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANGIE PLATT FY17-19</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JERRY WISLER FY17-19</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KAREY L WITTY FY17-19</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GRANT BEARD FY18-20</PersonNm>
        <TitleTxt>CHAIR, FINANCE</TitleTxt>
        <AverageHoursPerWeekRt>10.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BRANDON ARBITER FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>STEVEN DAVIS FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CATHY BAIER FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARY ELIZABETH BUNZEL FY18-19</PersonNm>
        <TitleTxt>CHAIT, CHANCELLORS</TitleTxt>
        <AverageHoursPerWeekRt>5.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JENNIFER BENNETT FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOE LACHER FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KIM ROOSEVELT FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CHRISTOPHER TURNER FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MATT VAREY FY18-20</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DEREK RAPP</PersonNm>
        <TitleTxt>PRESIDENT AND CEO</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>850000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>47460</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SANDRA HIJIKATA</PersonNm>
        <TitleTxt>CHIEF DEV OFFICER &amp; ASST. SECY</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>395000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>18348</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARK GREENE</PersonNm>
        <TitleTxt>CFO &amp; ASST. TRES</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>398000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>26205</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JILL CLARK</PersonNm>
        <TitleTxt>CHIEF OF STAFF &amp; ASST. SECY</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>289041</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>17309</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JONATHAN R BEHR</PersonNm>
        <TitleTxt>MANAGING DIRECTOR JDRF-T1D FND</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <KeyEmployeeInd>X</KeyEmployeeInd>
        <ReportableCompFromOrgAmt>372500</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>34761</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>AARON KOWALSKI</PersonNm>
        <TitleTxt>CHIEF MISSION OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>418091</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>42152</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>STEVEN GRIFFEN MD</PersonNm>
        <TitleTxt>SVP RESEARCH</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>326430</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>36664</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ALISA NORRIS</PersonNm>
        <TitleTxt>CHIEF MARKETING OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>374755</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>47422</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JULIA GREENSTEIN</PersonNm>
        <TitleTxt>VP RESEARCH</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>315790</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>14636</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SUSAN YUN</PersonNm>
        <TitleTxt>CHIEF PEOPLE OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>50.0</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.0</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>303455</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>19942</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>4043062</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>304899</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>162</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>DDC ADVOCACY</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>805 15th Street NW</AddressLine1Txt>
            <CityNm>WASHINGTON</CityNm>
            <StateAbbreviationCd>DC</StateAbbreviationCd>
            <ZIPCd>20005</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>LEGISLATIVE CONSULT</ServicesDesc>
        <CompensationAmt>497250</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>10UP LLC</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>2765 CARRADALE DR</AddressLine1Txt>
            <CityNm>ROSEVILLE</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>95661</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>WEB DEVELOPMENT</ServicesDesc>
        <CompensationAmt>338199</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>CDS GLOBAL</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>1901 BELL AVE</AddressLine1Txt>
            <CityNm>DES MOINES</CityNm>
            <StateAbbreviationCd>IA</StateAbbreviationCd>
            <ZIPCd>50315</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>3RD PARTY LOCK BOX</ServicesDesc>
        <CompensationAmt>583780</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>BLUE STATE DIGITAL</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>101 AVE OF THE AMERICAS</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10013</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>DIGITAL CONSULTING</ServicesDesc>
        <CompensationAmt>479119</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <PersonNm>AKA ENTERPRISE SOLUTIONS</PersonNm>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>875 SIXTH AVE 20th FLOOR</AddressLine1Txt>
            <CityNm>NEW YORK</CityNm>
            <StateAbbreviationCd>NY</StateAbbreviationCd>
            <ZIPCd>10001</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>EPM IMPLEMENTATION</ServicesDesc>
        <CompensationAmt>710885</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>51</CntrctRcvdGreaterThan100KCnt>
      <FederatedCampaignsAmt>4294747</FederatedCampaignsAmt>
      <FundraisingAmt>127990024</FundraisingAmt>
      <AllOtherContributionsAmt>87683334</AllOtherContributionsAmt>
      <NoncashContributionsAmt>20144817</NoncashContributionsAmt>
      <TotalContributionsAmt>219968105</TotalContributionsAmt>
      <TotalProgramServiceRevenueAmt>0</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>1326587</TotalRevenueColumnAmt>
        <UnrelatedBusinessRevenueAmt>17064</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>1309523</ExclusionAmt>
      </InvestmentIncomeGrp>
      <IncmFromInvestBondProceedsGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </IncmFromInvestBondProceedsGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </RoyaltiesRevenueGrp>
      <RentalIncomeOrLossGrp>
        <RealAmt>0</RealAmt>
        <PersonalAmt>0</PersonalAmt>
      </RentalIncomeOrLossGrp>
      <NetRentalIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetRentalIncomeOrLossGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>7651000</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>1800586</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>5850414</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>5850414</TotalRevenueColumnAmt>
        <ExclusionAmt>5850414</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <FundraisingGrossIncomeAmt>28454512</FundraisingGrossIncomeAmt>
      <ContriRptFundraisingEventAmt>127990024</ContriRptFundraisingEventAmt>
      <FundraisingDirectExpensesAmt>28454512</FundraisingDirectExpensesAmt>
      <GamingGrossIncomeAmt>1423288</GamingGrossIncomeAmt>
      <GamingDirectExpensesAmt>245454</GamingDirectExpensesAmt>
      <NetIncomeFromGamingGrp>
        <TotalRevenueColumnAmt>1177834</TotalRevenueColumnAmt>
        <ExclusionAmt>1177834</ExclusionAmt>
      </NetIncomeFromGamingGrp>
      <GrossSalesOfInventoryAmt>0</GrossSalesOfInventoryAmt>
      <CostOfGoodsSoldAmt>0</CostOfGoodsSoldAmt>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>0</TotalRevenueColumnAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISC PROGRAM REVENUE</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1793044</TotalRevenueColumnAmt>
        <ExclusionAmt>1793044</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>1793044</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>230115984</TotalRevenueColumnAmt>
        <UnrelatedBusinessRevenueAmt>17064</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>10130815</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>61518639</TotalAmt>
        <ProgramServicesAmt>61518639</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>0</TotalAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>23133341</TotalAmt>
        <ProgramServicesAmt>23133341</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <BenefitsToMembersGrp>
        <TotalAmt>0</TotalAmt>
      </BenefitsToMembersGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>2481235</TotalAmt>
        <ProgramServicesAmt>1488741</ProgramServicesAmt>
        <ManagementAndGeneralAmt>347373</ManagementAndGeneralAmt>
        <FundraisingAmt>645121</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <CompDisqualPersonsGrp>
        <TotalAmt>60427</TotalAmt>
        <ProgramServicesAmt>36256</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8460</ManagementAndGeneralAmt>
        <FundraisingAmt>15711</FundraisingAmt>
      </CompDisqualPersonsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>62676897</TotalAmt>
        <ProgramServicesAmt>42318201</ProgramServicesAmt>
        <ManagementAndGeneralAmt>7220843</ManagementAndGeneralAmt>
        <FundraisingAmt>13137853</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>1983990</TotalAmt>
        <ProgramServicesAmt>1347990</ProgramServicesAmt>
        <ManagementAndGeneralAmt>277759</ManagementAndGeneralAmt>
        <FundraisingAmt>358241</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>4458573</TotalAmt>
        <ProgramServicesAmt>2671984</ProgramServicesAmt>
        <ManagementAndGeneralAmt>624200</ManagementAndGeneralAmt>
        <FundraisingAmt>1162389</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>9772065</TotalAmt>
        <ProgramServicesAmt>5860926</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1368089</ManagementAndGeneralAmt>
        <FundraisingAmt>2543050</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>3014034</TotalAmt>
        <ProgramServicesAmt>1325412</ProgramServicesAmt>
        <ManagementAndGeneralAmt>591831</ManagementAndGeneralAmt>
        <FundraisingAmt>1096791</FundraisingAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>679672</TotalAmt>
        <ProgramServicesAmt>407803</ProgramServicesAmt>
        <ManagementAndGeneralAmt>95154</ManagementAndGeneralAmt>
        <FundraisingAmt>176715</FundraisingAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>189821</TotalAmt>
        <ProgramServicesAmt>113893</ProgramServicesAmt>
        <ManagementAndGeneralAmt>26575</ManagementAndGeneralAmt>
        <FundraisingAmt>49353</FundraisingAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesLobbyingGrp>
        <TotalAmt>1211012</TotalAmt>
        <ProgramServicesAmt>1211012</ProgramServicesAmt>
      </FeesForServicesLobbyingGrp>
      <FeesForServicesProfFundraising>
        <TotalAmt>2328</TotalAmt>
        <FundraisingAmt>2328</FundraisingAmt>
      </FeesForServicesProfFundraising>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>449309</TotalAmt>
        <ManagementAndGeneralAmt>449309</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>2431813</TotalAmt>
        <ProgramServicesAmt>1459088</ProgramServicesAmt>
        <ManagementAndGeneralAmt>340454</ManagementAndGeneralAmt>
        <FundraisingAmt>632271</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>5116784</TotalAmt>
        <ProgramServicesAmt>3070070</ProgramServicesAmt>
        <ManagementAndGeneralAmt>716350</ManagementAndGeneralAmt>
        <FundraisingAmt>1330364</FundraisingAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>1125442</TotalAmt>
        <ProgramServicesAmt>686520</ProgramServicesAmt>
        <ManagementAndGeneralAmt>191325</ManagementAndGeneralAmt>
        <FundraisingAmt>247597</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>4458076</TotalAmt>
        <ProgramServicesAmt>2719426</ProgramServicesAmt>
        <ManagementAndGeneralAmt>757873</ManagementAndGeneralAmt>
        <FundraisingAmt>980777</FundraisingAmt>
      </InformationTechnologyGrp>
      <RoyaltiesGrp>
        <TotalAmt>0</TotalAmt>
      </RoyaltiesGrp>
      <OccupancyGrp>
        <TotalAmt>8138531</TotalAmt>
        <ProgramServicesAmt>4881813</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1135477</ManagementAndGeneralAmt>
        <FundraisingAmt>2121241</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>2977590</TotalAmt>
        <ProgramServicesAmt>1786554</ProgramServicesAmt>
        <ManagementAndGeneralAmt>416863</ManagementAndGeneralAmt>
        <FundraisingAmt>774173</FundraisingAmt>
      </TravelGrp>
      <PymtTravelEntrtnmntPubOfclGrp>
        <TotalAmt>0</TotalAmt>
      </PymtTravelEntrtnmntPubOfclGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>2594270</TotalAmt>
        <ProgramServicesAmt>1556562</ProgramServicesAmt>
        <ManagementAndGeneralAmt>363198</ManagementAndGeneralAmt>
        <FundraisingAmt>674510</FundraisingAmt>
      </ConferencesMeetingsGrp>
      <InterestGrp>
        <TotalAmt>0</TotalAmt>
      </InterestGrp>
      <PaymentsToAffiliatesGrp>
        <TotalAmt>0</TotalAmt>
      </PaymentsToAffiliatesGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>4333042</TotalAmt>
        <ProgramServicesAmt>2643156</ProgramServicesAmt>
        <ManagementAndGeneralAmt>736617</ManagementAndGeneralAmt>
        <FundraisingAmt>953269</FundraisingAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>501201</TotalAmt>
        <ProgramServicesAmt>304730</ProgramServicesAmt>
        <ManagementAndGeneralAmt>86708</ManagementAndGeneralAmt>
        <FundraisingAmt>109763</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>OUTREACH EXPENSES</Desc>
        <TotalAmt>2586429</TotalAmt>
        <ProgramServicesAmt>1646521</ProgramServicesAmt>
        <ManagementAndGeneralAmt>355375</ManagementAndGeneralAmt>
        <FundraisingAmt>584533</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>DUES &amp; FEES</Desc>
        <TotalAmt>1424567</TotalAmt>
        <ProgramServicesAmt>906879</ProgramServicesAmt>
        <ManagementAndGeneralAmt>195736</ManagementAndGeneralAmt>
        <FundraisingAmt>321952</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>OTHER MISC EXPENSES</Desc>
        <TotalAmt>1108587</TotalAmt>
        <ProgramServicesAmt>979112</ProgramServicesAmt>
        <ManagementAndGeneralAmt>63239</ManagementAndGeneralAmt>
        <FundraisingAmt>66236</FundraisingAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>208427675</TotalAmt>
        <ProgramServicesAmt>164074629</ProgramServicesAmt>
        <ManagementAndGeneralAmt>16368808</ManagementAndGeneralAmt>
        <FundraisingAmt>27984238</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <JointCostsInd>X</JointCostsInd>
      <TotalJointCostsGrp>
        <TotalAmt>2026999</TotalAmt>
        <ProgramServicesAmt>719323</ProgramServicesAmt>
        <ManagementAndGeneralAmt>111224</ManagementAndGeneralAmt>
        <FundraisingAmt>1196451</FundraisingAmt>
      </TotalJointCostsGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>23695495</BOYAmt>
        <EOYAmt>14717083</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>30545972</BOYAmt>
        <EOYAmt>56336253</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>28143186</BOYAmt>
        <EOYAmt>29143990</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <AccountsReceivableGrp>
        <BOYAmt>14274402</BOYAmt>
        <EOYAmt>21529716</EOYAmt>
      </AccountsReceivableGrp>
      <ReceivablesFromOfficersEtcGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </ReceivablesFromOfficersEtcGrp>
      <RcvblFromDisqualifiedPrsnGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </RcvblFromDisqualifiedPrsnGrp>
      <OthNotesLoansReceivableNetGrp>
        <BOYAmt>5000000</BOYAmt>
        <EOYAmt>1500000</EOYAmt>
      </OthNotesLoansReceivableNetGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>5592386</BOYAmt>
        <EOYAmt>5991334</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>25831752</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>18502543</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>9719880</BOYAmt>
        <EOYAmt>7329209</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>38164626</BOYAmt>
        <EOYAmt>47882217</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>39867626</BOYAmt>
        <EOYAmt>30662349</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <InvestmentsProgramRelatedGrp>
        <BOYAmt>3750000</BOYAmt>
        <EOYAmt>11261030</EOYAmt>
      </InvestmentsProgramRelatedGrp>
      <IntangibleAssetsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </IntangibleAssetsGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>198753573</BOYAmt>
        <EOYAmt>226353181</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>16729137</BOYAmt>
        <EOYAmt>22350808</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <GrantsPayableGrp>
        <BOYAmt>94060180</BOYAmt>
        <EOYAmt>94919621</EOYAmt>
      </GrantsPayableGrp>
      <DeferredRevenueGrp>
        <BOYAmt>7934693</BOYAmt>
        <EOYAmt>10051979</EOYAmt>
      </DeferredRevenueGrp>
      <TaxExemptBondLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </TaxExemptBondLiabilitiesGrp>
      <EscrowAccountLiabilityGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </EscrowAccountLiabilityGrp>
      <LoansFromOfficersDirectorsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </LoansFromOfficersDirectorsGrp>
      <MortgNotesPyblScrdInvstPropGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </MortgNotesPyblScrdInvstPropGrp>
      <UnsecuredNotesLoansPayableGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </UnsecuredNotesLoansPayableGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>2661059</BOYAmt>
        <EOYAmt>2625288</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>121385069</BOYAmt>
        <EOYAmt>129947696</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>39586000</BOYAmt>
        <EOYAmt>57009483</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>30441504</BOYAmt>
        <EOYAmt>31828002</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <PermanentlyRstrNetAssetsGrp>
        <BOYAmt>7341000</BOYAmt>
        <EOYAmt>7568000</EOYAmt>
      </PermanentlyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>77368504</BOYAmt>
        <EOYAmt>96405485</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>198753573</BOYAmt>
        <EOYAmt>226353181</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>21688309</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-2651328</NetUnrlzdGainsLossesInvstAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolidatedBasisFinclStmtInd>X</ConsolidatedBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="IRS990ScheduleA">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>210068935</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>198918214</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>196804267</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>199896852</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>219968105</CurrentTaxYearAmt>
        <TotalAmt>1025656373</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TaxRevLeviedOrgnztnlBnft170Grp>
        <TotalAmt>0</TotalAmt>
      </TaxRevLeviedOrgnztnlBnft170Grp>
      <GovtFurnSrvcFcltsVl170Grp>
        <TotalAmt>0</TotalAmt>
      </GovtFurnSrvcFcltsVl170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>210068935</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>198918214</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>196804267</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>199896852</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>219968105</CurrentTaxYearAmt>
        <TotalAmt>1025656373</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>7606983</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>1018049390</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>1646615</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>987577</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>465379</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>548825</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1309523</CurrentTaxYearAmt>
        <TotalAmt>4957919</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <UnrelatedBusinessNetIncm170Grp>
        <CurrentTaxYearMinus4YearsAmt>6810</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>2516</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>112437</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>33150</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>17064</CurrentTaxYearAmt>
        <TotalAmt>171977</TotalAmt>
      </UnrelatedBusinessNetIncm170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>136667</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>256146</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>94769</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>283014</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1793044</CurrentTaxYearAmt>
        <TotalAmt>2563640</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>1033349909</TotalSupportAmt>
      <PublicSupportCY170Pct>0.98519</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.98793</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="IRS990ScheduleB" />
    <IRS990ScheduleC documentId="IRS990ScheduleC">
      <TotalGrassrootsLobbyingGrp />
      <TotalDirectLobbyingGrp />
      <TotalLobbyingExpendGrp />
      <OtherExemptPurposeExpendGrp />
      <TotalExemptPurposeExpendGrp />
      <LobbyingNontaxableAmountGrp />
      <GrassrootsNontaxableGrp />
      <TotLbbyngGrassrootMnsNonTxGrp />
      <TotLbbyExpendMnsLbbyngNonTxGrp />
      <Form4720FiledInd>false</Form4720FiledInd>
      <VolunteersInd>true</VolunteersInd>
      <PaidStaffOrManagementInd>true</PaidStaffOrManagementInd>
      <MediaAdvertisementsInd>true</MediaAdvertisementsInd>
      <MediaAdvertisementsAmt>807</MediaAdvertisementsAmt>
      <MailingsMembersInd>true</MailingsMembersInd>
      <MailingsMembersAmt>85018</MailingsMembersAmt>
      <PublicationsOrBroadcastInd>false</PublicationsOrBroadcastInd>
      <GrantsOtherOrganizationsInd>true</GrantsOtherOrganizationsInd>
      <GrantsOtherOrganizationsAmt>548</GrantsOtherOrganizationsAmt>
      <DirectContactLegislatorsInd>true</DirectContactLegislatorsInd>
      <DirectContactLegislatorsAmt>847570</DirectContactLegislatorsAmt>
      <RalliesDemonstrationsInd>true</RalliesDemonstrationsInd>
      <RalliesDemonstrationsAmt>505331</RalliesDemonstrationsAmt>
      <OtherActivitiesInd>false</OtherActivitiesInd>
      <TotalLobbyingExpendituresAmt>1439274</TotalLobbyingExpendituresAmt>
      <NotDescribedSection501c3Ind>false</NotDescribedSection501c3Ind>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>JDRF LOBBYING ACTIVITIES</FormAndLineReferenceDesc>
        <ExplanationTxt>FORM 990- SCH-C- GENERAL STATEMENT OF ACTIVITIES JDRF is the leading global organization funding type 1 diabetes (T1D) research. Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. Through research and advocacy, JDRF is accelerating progress on the most promising opportunities to cure, prevent and treat T1D and its complications. JDRF's advocacy includes lobbying activity to ensure Congress continues to invest in critically important medical research and puts in place policies to advance the discovery, development, and delivery of better therapies for T1D. JDRF has been instrumental in securing the renewal of the Special Diabetes Program, which provides $150MM annually for T1D research at the National Institutes of Health. JDRF staff and volunteers communicate with government officials through email, phone calls, and meetings, to educate them on issues and encourage the advancement of legislation.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleC>
    <IRS990ScheduleD documentId="IRS990ScheduleD">
      <ArtPublicExhibitionAmountsGrp />
      <HeldWorksArtGrp />
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>7341367</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>268304</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>42070</OtherExpendituresAmt>
        <EndYearBalanceAmt>7567601</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>7176427</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>367446</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>202506</OtherExpendituresAmt>
        <EndYearBalanceAmt>7341367</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>7141514</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>37913</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>3000</OtherExpendituresAmt>
        <EndYearBalanceAmt>7176427</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>7426222</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>11292</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>296000</OtherExpendituresAmt>
        <EndYearBalanceAmt>7141514</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>6837461</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>625761</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>37000</OtherExpendituresAmt>
        <EndYearBalanceAmt>7426222</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <PrmnntEndowmentBalanceEOYPct>1.00000</PrmnntEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>false</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>false</EndowmentsHeldRelatedOrgInd>
      <LandGrp />
      <BuildingsGrp />
      <LeaseholdImprovementsGrp>
        <OtherCostOrOtherBasisAmt>4786090</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>3855564</DepreciationAmt>
        <BookValueAmt>930526</BookValueAmt>
      </LeaseholdImprovementsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>21045661</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>14646979</DepreciationAmt>
        <BookValueAmt>6398682</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp />
      <TotalBookValueLandBuildingsAmt>7329208</TotalBookValueLandBuildingsAmt>
      <FinancialDerivativesGrp />
      <CloselyHeldEquityInterestsGrp />
      <OtherSecuritiesGrp>
        <Desc>HEDGE FUNDS</Desc>
        <BookValueAmt>19209614</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <OtherSecuritiesGrp>
        <Desc>US-NON-PUBLIC INVESTMENT FUNDS</Desc>
        <BookValueAmt>11452735</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <TotalBookValueSecuritiesAmt>30662349</TotalBookValueSecuritiesAmt>
      <FederalIncomeTaxLiabilityAmt>0</FederalIncomeTaxLiabilityAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>SPLIT INTEREST CHRT RMDR TRUST</Desc>
        <Amt>2625288</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>2625288</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>227015347</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>-2651328</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>-2651328</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>229666675</RevenueSubtotalAmt>
      <InvestmentExpensesNotIncldAmt>449309</InvestmentExpensesNotIncldAmt>
      <RevenueNotReportedFinclStmtAmt>449309</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>230115984</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>207978366</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesSubtotalAmt>207978366</ExpensesSubtotalAmt>
      <InvestmentExpensesNotIncld2Amt>449309</InvestmentExpensesNotIncld2Amt>
      <ExpensesNotRptFinclStmtAmt>449309</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>208427675</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>ORGANIZATION'S ENDOWMENT FUNDS</FormAndLineReferenceDesc>
        <ExplanationTxt>FORM 990, PART X, LINE 28 &amp; 29 &amp; SCH D, PART V THE ORGANIZATION UTILIZES EARNINGS ON ENDOWMENT FUNDS IN THE MANNER SPECIFIED BY THE DONOR AND/OR FOR SUPPORTING THE ORGANIZATIONS GENERAL EXEMPT PURPOSE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>INCOME TAX POSITION OF JDRF INT.</FormAndLineReferenceDesc>
        <ExplanationTxt>990 SCH-D, PART X, LINE 2 JDRF IS A NOT FOR PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501 (C) (3) OF THE INTERNAL REVENUE CODE AND IS ORGANIZED UNDER THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA. INCOME GENERATED FROM ACTIVITIES UNRELATED TO JDRF'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. INCOME TAX LIABILITIES ARE RECOGNIZED WHEN SUCH POSITIONS ARE QUANTIFIABLE AND LIKELY TO BE REALIZED. UNRELATED BUSINESS INCOME TAX LIABILITY WAS INSIGNIFICANT FOR THE YEARS ENDING JUNE 30, 2018 AND 2017.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="IRS990ScheduleF">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <TypeOfActivitiesConductedTxt>Grantmaking</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>RESEARCH GRANTS</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>3662429</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Middle East and North Africa</RegionTxt>
        <TypeOfActivitiesConductedTxt>Grantmaking</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>RESEARCH GRANTS</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>543725</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <TypeOfActivitiesConductedTxt>Grantmaking</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>RESEARCH GRANTS</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>4450088</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <TypeOfActivitiesConductedTxt>Grantmaking</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>RESEARCH GRANTS</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>14477099</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <OfficesCnt>2</OfficesCnt>
        <EmployeeCnt>2</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>Program Services</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>RESEARCH SUPPORT</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>302393</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>Central America and the Caribbean</RegionTxt>
        <TypeOfActivitiesConductedTxt>Investments</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>Investments</SpecificServicesProvidedTxt>
        <RegionTotalExpendituresAmt>4963929</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>2</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>2</SubtotalEmployeesCnt>
      <TotalOfficeCnt>2</TotalOfficeCnt>
      <TotalEmployeeCnt>2</TotalEmployeeCnt>
      <SubtotalSpentAmt>28399663</SubtotalSpentAmt>
      <TotalSpentAmt>28399663</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>115000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <CashGrantAmt>249243</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>125165</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>930622</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Middle East and North Africa</RegionTxt>
        <CashGrantAmt>328734</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>1431786</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <CashGrantAmt>60419</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <CashGrantAmt>311315</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>297112</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>64728</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <CashGrantAmt>200000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <CashGrantAmt>395332</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <CashGrantAmt>1194079</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>110000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>172535</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>183460</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <CashGrantAmt>529939</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>60816</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>248600</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <CashGrantAmt>603376</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>120000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>249561</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>124403</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>250000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>247317</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <CashGrantAmt>906704</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <CashGrantAmt>64728</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>200000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>458238</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>191237</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>432961</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <CashGrantAmt>342276</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <PurposeOfGrantTxt>ARTIFICIAL PANCREAS</PurposeOfGrantTxt>
        <CashGrantAmt>250000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>233283</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THEPAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>58779</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>112355</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Middle East and North Africa</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>109991</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Middle East and North Africa</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>105000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>529908</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <CashGrantAmt>250000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <CashGrantAmt>1297298</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>BETA CELL</PurposeOfGrantTxt>
        <CashGrantAmt>413885</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>430950</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>118496</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>247500</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>883066</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>69570</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>99532</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>BETA CELL</PurposeOfGrantTxt>
        <CashGrantAmt>125000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>215000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>625737</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>238465</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>70000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>95067</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>East Asia and the Pacific</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>250000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>649999</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>955880</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>349659</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>149767</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>1461283</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>96377</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>174838</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>Europe (Including Iceland and Greenland)</RegionTxt>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
        <CashGrantAmt>1026547</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>North America</RegionTxt>
        <CashGrantAmt>250000</CashGrantAmt>
        <MannerOfCashDisbursementTxt>CHECK/WIRE</MannerOfCashDisbursementTxt>
        <DescriptionOfNonCashAsstTxt>N/A</DescriptionOfNonCashAsstTxt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>43</Total501c3OrgCnt>
      <TotalOtherOrgCnt>21</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>true</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>false</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>true</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>true</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>false</ForeignPartnershipInd>
      <BoycottCountriesInd>false</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>GRANT MONITORING PROCEDURES</FormAndLineReferenceDesc>
        <ExplanationTxt>SCH-F PART I LINE 2 Research grants are awarded by JDRF's Research Committee comprised of "JDRF Board members and other volunteers" following the recommendations of an in-house team of professional scientific staff and with input from external scientific reviewers and patient advocates. The review process includes the following criteria: (1) The scientific merit of the proposed research outlined in a grant application and (2) The relationship of the proposed research to JDRF's goal to cure, prevent and treat T1D and its complications. The scientific research team and grant administration staff maintain close contact with grantees, providing advice, evaluation, research progress reports, helping disseminate research results and reviewing research expenditures versus agreed budgets.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleG documentId="IRS990ScheduleG">
      <MailSolicitationsInd>X</MailSolicitationsInd>
      <EmailSolicitationsInd>X</EmailSolicitationsInd>
      <SolicitationOfNonGovtGrantsInd>X</SolicitationOfNonGovtGrantsInd>
      <SolicitationOfGovtGrantsInd>X</SolicitationOfGovtGrantsInd>
      <SpecialFundraisingEventsInd>X</SpecialFundraisingEventsInd>
      <AgrmtProfFundraisingActyInd>true</AgrmtProfFundraisingActyInd>
      <FundraiserActivityInfoGrp>
        <PersonNm>AUTOMATIVE RECOVERY SERV</PersonNm>
        <USAddress>
          <AddressLine1Txt>TWO WESTBROOK CORORATE CENTER SUIT</AddressLine1Txt>
          <CityNm>WESTCHESTER</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60154</ZIPCd>
        </USAddress>
        <ActivityTxt>CAR DONATION</ActivityTxt>
        <FundraiserControlOfFundsInd>true</FundraiserControlOfFundsInd>
        <GrossReceiptsAmt>261400</GrossReceiptsAmt>
        <RetainedByContractorAmt>107183</RetainedByContractorAmt>
        <NetToOrganizationAmt>154217</NetToOrganizationAmt>
      </FundraiserActivityInfoGrp>
      <TotalGrossReceiptsAmt>261400</TotalGrossReceiptsAmt>
      <TotalRetainedByContractorsAmt>107183</TotalRetainedByContractorsAmt>
      <TotalNetToOrganizationAmt>154217</TotalNetToOrganizationAmt>
      <LicensedStatesCd>AL</LicensedStatesCd>
      <LicensedStatesCd>AK</LicensedStatesCd>
      <LicensedStatesCd>AZ</LicensedStatesCd>
      <LicensedStatesCd>AR</LicensedStatesCd>
      <LicensedStatesCd>CA</LicensedStatesCd>
      <LicensedStatesCd>CO</LicensedStatesCd>
      <LicensedStatesCd>CT</LicensedStatesCd>
      <LicensedStatesCd>DE</LicensedStatesCd>
      <LicensedStatesCd>DC</LicensedStatesCd>
      <LicensedStatesCd>FL</LicensedStatesCd>
      <LicensedStatesCd>GA</LicensedStatesCd>
      <LicensedStatesCd>HI</LicensedStatesCd>
      <LicensedStatesCd>ID</LicensedStatesCd>
      <LicensedStatesCd>IL</LicensedStatesCd>
      <LicensedStatesCd>IN</LicensedStatesCd>
      <LicensedStatesCd>IA</LicensedStatesCd>
      <LicensedStatesCd>KS</LicensedStatesCd>
      <LicensedStatesCd>KY</LicensedStatesCd>
      <LicensedStatesCd>LA</LicensedStatesCd>
      <LicensedStatesCd>ME</LicensedStatesCd>
      <LicensedStatesCd>MD</LicensedStatesCd>
      <LicensedStatesCd>MA</LicensedStatesCd>
      <LicensedStatesCd>MI</LicensedStatesCd>
      <LicensedStatesCd>MN</LicensedStatesCd>
      <LicensedStatesCd>MS</LicensedStatesCd>
      <LicensedStatesCd>MO</LicensedStatesCd>
      <LicensedStatesCd>MT</LicensedStatesCd>
      <LicensedStatesCd>NE</LicensedStatesCd>
      <LicensedStatesCd>NV</LicensedStatesCd>
      <LicensedStatesCd>NH</LicensedStatesCd>
      <LicensedStatesCd>NJ</LicensedStatesCd>
      <LicensedStatesCd>NM</LicensedStatesCd>
      <LicensedStatesCd>NY</LicensedStatesCd>
      <LicensedStatesCd>NC</LicensedStatesCd>
      <LicensedStatesCd>ND</LicensedStatesCd>
      <LicensedStatesCd>OH</LicensedStatesCd>
      <LicensedStatesCd>OK</LicensedStatesCd>
      <LicensedStatesCd>OR</LicensedStatesCd>
      <LicensedStatesCd>PA</LicensedStatesCd>
      <LicensedStatesCd>RI</LicensedStatesCd>
      <LicensedStatesCd>SC</LicensedStatesCd>
      <LicensedStatesCd>SD</LicensedStatesCd>
      <LicensedStatesCd>TN</LicensedStatesCd>
      <LicensedStatesCd>TX</LicensedStatesCd>
      <LicensedStatesCd>UT</LicensedStatesCd>
      <LicensedStatesCd>VT</LicensedStatesCd>
      <LicensedStatesCd>VA</LicensedStatesCd>
      <LicensedStatesCd>WA</LicensedStatesCd>
      <LicensedStatesCd>WV</LicensedStatesCd>
      <LicensedStatesCd>WI</LicensedStatesCd>
      <LicensedStatesCd>WY</LicensedStatesCd>
      <FundraisingEventInformationGrp>
        <Event1Nm>ILLINOIS GALA</Event1Nm>
        <GrossReceiptsEvent1Amt>4981354</GrossReceiptsEvent1Amt>
        <CharitableContriEvent1Amt>4121472</CharitableContriEvent1Amt>
        <GrossRevenueEvent1Amt>859882</GrossRevenueEvent1Amt>
        <NonCashPrizesEvent1Amt>13</NonCashPrizesEvent1Amt>
        <RentFacilityCostsEvent1Amt>70748</RentFacilityCostsEvent1Amt>
        <FoodAndBeverageEvent1Amt>333740</FoodAndBeverageEvent1Amt>
        <EntertainmentEvent1Amt>332072</EntertainmentEvent1Amt>
        <OtherDirectExpensesEvent1Amt>123309</OtherDirectExpensesEvent1Amt>
        <Event2Nm>ILLINOIS WALK</Event2Nm>
        <GrossReceiptsEvent2Amt>3859625</GrossReceiptsEvent2Amt>
        <CharitableContriEvent2Amt>3488799</CharitableContriEvent2Amt>
        <GrossRevenueEvent2Amt>370826</GrossRevenueEvent2Amt>
        <NonCashPrizesEvent2Amt>13604</NonCashPrizesEvent2Amt>
        <FoodAndBeverageEvent2Amt>8829</FoodAndBeverageEvent2Amt>
        <EntertainmentEvent2Amt>8356</EntertainmentEvent2Amt>
        <OtherDirectExpensesEvent2Amt>260800</OtherDirectExpensesEvent2Amt>
        <OtherEventsTotalCnt>364</OtherEventsTotalCnt>
        <GrossReceiptsOtherEventsAmt>147603557</GrossReceiptsOtherEventsAmt>
        <CharitableContriOtherEventsAmt>120379753</CharitableContriOtherEventsAmt>
        <GrossRevenueOtherEventsAmt>27223804</GrossRevenueOtherEventsAmt>
        <NonCashPrizesOtherEventsAmt>82193</NonCashPrizesOtherEventsAmt>
        <RentFcltyCostsOtherEventsAmt>3765120</RentFcltyCostsOtherEventsAmt>
        <FoodAndBeverageOtherEventsAmt>2732904</FoodAndBeverageOtherEventsAmt>
        <EntertainmentOtherEventsAmt>3286150</EntertainmentOtherEventsAmt>
        <OthDirectExpnssOtherEventsAmt>17436674</OthDirectExpnssOtherEventsAmt>
        <GrossReceiptsTotalAmt>156444536</GrossReceiptsTotalAmt>
        <CharitableContributionsTotAmt>127990024</CharitableContributionsTotAmt>
        <GrossRevenueTotalEventsAmt>28454512</GrossRevenueTotalEventsAmt>
        <NonCashPrizesTotalEventsAmt>95810</NonCashPrizesTotalEventsAmt>
        <RentFcltyCostsTotalEventsAmt>3835868</RentFcltyCostsTotalEventsAmt>
        <FoodAndBeverageTotalEventsAmt>3075473</FoodAndBeverageTotalEventsAmt>
        <EntertainmentTotalEventsAmt>3626578</EntertainmentTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>17820783</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>28454512</DirectExpenseSummaryEventsAmt>
      </FundraisingEventInformationGrp>
      <GamingInformationGrp>
        <GrossRevenueOtherGamingAmt>1423288</GrossRevenueOtherGamingAmt>
        <CashPrizesOtherGamingAmt>20000</CashPrizesOtherGamingAmt>
        <NonCashPrizesOtherGamingAmt>225454</NonCashPrizesOtherGamingAmt>
        <VolunteerLaborOtherGamingInd>false</VolunteerLaborOtherGamingInd>
        <GrossRevenueTotalGamingAmt>1423288</GrossRevenueTotalGamingAmt>
        <CashPrizesTotalGamingAmt>20000</CashPrizesTotalGamingAmt>
        <NonCashPrizesTotalGamingAmt>225454</NonCashPrizesTotalGamingAmt>
        <DirectExpenseSummaryGamingAmt>245454</DirectExpenseSummaryGamingAmt>
        <NetGamingIncomeSummaryAmt>1177834</NetGamingIncomeSummaryAmt>
      </GamingInformationGrp>
      <StatesWhereGamingConductedCd>AL</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>AK</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>AZ</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>AR</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>CA</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>CO</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>CT</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>DE</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>DC</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>FL</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>GA</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>HI</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>ID</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>IL</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>IN</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>IA</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>KS</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>KY</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>LA</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>ME</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>MD</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>MA</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>MI</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>MN</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>MS</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>MO</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>MT</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>NE</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>NV</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>NH</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>NJ</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>NM</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>NY</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>NC</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>ND</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>OK</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>OR</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>PW</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>PA</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>RI</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>SC</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>SD</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>TN</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>TX</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>UT</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>VT</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>VA</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>WA</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>WV</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>WI</StatesWhereGamingConductedCd>
      <StatesWhereGamingConductedCd>WY</StatesWhereGamingConductedCd>
      <LicensedInd>true</LicensedInd>
      <LicenseSuspendedEtcInd>false</LicenseSuspendedEtcInd>
      <GamingWithNonmembersInd>false</GamingWithNonmembersInd>
      <MemberOfOtherEntityInd>false</MemberOfOtherEntityInd>
      <GamingOtherFacilityPct>1.00000</GamingOtherFacilityPct>
      <IndividualWithBooksNm>GARY CURTO</IndividualWithBooksNm>
      <PersonsWithBooksUSAddress>
        <AddressLine1Txt>26 BROADWAY-14TH FLOOR</AddressLine1Txt>
        <CityNm>NEW YORK</CityNm>
        <StateAbbreviationCd>NY</StateAbbreviationCd>
        <ZIPCd>10004</ZIPCd>
      </PersonsWithBooksUSAddress>
      <CntrctWith3rdPrtyForGameRevInd>false</CntrctWith3rdPrtyForGameRevInd>
      <GamingManagerPersonNm>GARY CURTO TAX MANAGER -JDRF</GamingManagerPersonNm>
      <GamingManagerCompensationAmt>0</GamingManagerCompensationAmt>
      <GamingManagerServicesProvTxt>FILING GAMING APPLICATIONS AND REPORTS</GamingManagerServicesProvTxt>
      <GamingManagerIsEmployeeInd>X</GamingManagerIsEmployeeInd>
      <CharitableDistributionRqrInd>true</CharitableDistributionRqrInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE G, PART I, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>INSURANCE AUTO AUCTIONS LLC IS A STATE LICENSED PROFESSIONAL FUNDRAISER THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CONTACT THE COMPANY DIRECTLY THROUGH A TOLL FREE NUMBER TO COORDINATE THE DONATION, FOLLOWING WHICH INSURANCE AUTO AUCTIONS HANDLES ALL REQUIRED IRS 1098C REPORTING. FOR THE PERIOD ENDING 6/30/18, THE CAR PROGRAM RAISED $261,400 WITH TOTAL EXPENSES OF $107,183 WITH THE NET PROCEEDS OF $154,217 PROVIDED DIRECTLY TO JDRF. JDRF PAYS NO ADDITIONAL EXPENSES OR FEES TO INSURANCE AUTO AUCTIONS FOR THIS PROGRAM.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="IRS990ScheduleI">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BENAROYA RESEARCH INST AT VIRGINIA MASON</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1201 9TH AVE</AddressLine1Txt>
          <CityNm>SEATTLE</CityNm>
          <StateAbbreviationCd>WA</StateAbbreviationCd>
          <ZIPCd>98101</ZIPCd>
        </USAddress>
        <RecipientEIN>910653422</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>2098652</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>ANN AND ROBERT LURIE CHILDREN'S HOSPITAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>225 EAST CHICAGO AVENUE</AddressLine1Txt>
          <CityNm>CHICAGO</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60611</ZIPCd>
        </USAddress>
        <RecipientEIN>362170833</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>60000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CAPILLARY BIOMEDICAL INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>56 HAVENWOOD</AddressLine1Txt>
          <CityNm>IRVINE</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>92617</ZIPCd>
        </USAddress>
        <RecipientEIN>464787731</RecipientEIN>
        <CashGrantAmt>201500</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CASE WESTERN UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>10900 EUCLID AVE</AddressLine1Txt>
          <CityNm>CLEVELAND</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>44106</ZIPCd>
        </USAddress>
        <RecipientEIN>341018992</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>62640</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CORNELL UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>377 PINE TREE RD</AddressLine1Txt>
          <CityNm>ITHACA</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>14850</ZIPCd>
        </USAddress>
        <RecipientEIN>150532082</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>282000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CAM MED LLC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>29 EXETER STREET</AddressLine1Txt>
          <CityNm>WEST NEWTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02465</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <CashGrantAmt>100000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF ARIZONA</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO BOX 210158</AddressLine1Txt>
          <CityNm>TUCSON</CityNm>
          <StateAbbreviationCd>AZ</StateAbbreviationCd>
          <ZIPCd>85004</ZIPCd>
        </USAddress>
        <RecipientEIN>113661893</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>797276</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CRITICAL PATH INSTITUTE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1730 EAST RIVER ROAD</AddressLine1Txt>
          <CityNm>TUCSON</CityNm>
          <StateAbbreviationCd>AZ</StateAbbreviationCd>
          <ZIPCd>85718</ZIPCd>
        </USAddress>
        <RecipientEIN>201991334</RecipientEIN>
        <CashGrantAmt>151000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>INDIANA UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>980 INDIANA AVENUE</AddressLine1Txt>
          <CityNm>INDIANAPOLIS</CityNm>
          <StateAbbreviationCd>IN</StateAbbreviationCd>
          <ZIPCd>46202</ZIPCd>
        </USAddress>
        <RecipientEIN>356018940</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>937267</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BETH ISRAEL MEDICAL CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>330 BROOKLINE AVE</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02215</ZIPCd>
        </USAddress>
        <RecipientEIN>135564934</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>570000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>JOSLIN DIABETES CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1 JOSLIN PL</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02215</ZIPCd>
        </USAddress>
        <RecipientEIN>042203836</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>2117298</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>FREQENCY THERAPEUTICS</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>300 TECHNOLOGY SQUARE</AddressLine1Txt>
          <CityNm>WOBURN</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>01801</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <CashGrantAmt>35000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MASSACHUSETTS INSTITUTE OF TECHNOLOGY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>77 MASSACHUSETTS AVE</AddressLine1Txt>
          <CityNm>CAMBRIDGE</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02139</ZIPCd>
        </USAddress>
        <RecipientEIN>042103594</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>799829</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>INDIANA BIOSCIENCES RES INST</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1345 W 16TH STREET</AddressLine1Txt>
          <CityNm>INDIANAPOLIS</CityNm>
          <StateAbbreviationCd>IN</StateAbbreviationCd>
          <ZIPCd>46202</ZIPCd>
        </USAddress>
        <RecipientEIN>462882271</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>150000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CALIFORNIA INST FOR BIOMEDICAL RESEARCH</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>11119 NTORRY PINES RD</AddressLine1Txt>
          <CityNm>LAJOLLA</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>92037</ZIPCd>
        </USAddress>
        <RecipientEIN>956047739</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>2292400</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>EMORY UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>201 DOWMAN DRIVE</AddressLine1Txt>
          <CityNm>ATLANTA</CityNm>
          <StateAbbreviationCd>GA</StateAbbreviationCd>
          <ZIPCd>30322</ZIPCd>
        </USAddress>
        <RecipientEIN>580566256</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>359530</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MAYO CLINIC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1216 2ND ST SW</AddressLine1Txt>
          <CityNm>ROCHESTER</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55902</ZIPCd>
        </USAddress>
        <RecipientEIN>411405254</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>445564</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>GEORGIA TECH RESEARCH CORP</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>505 TENTH STREET</AddressLine1Txt>
          <CityNm>ATLANTA</CityNm>
          <StateAbbreviationCd>GA</StateAbbreviationCd>
          <ZIPCd>30332</ZIPCd>
        </USAddress>
        <RecipientEIN>580603146</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>167674</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>STANFORD UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>291 CAMPUS DRIVE</AddressLine1Txt>
          <CityNm>STANFORD</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>94305</ZIPCd>
        </USAddress>
        <RecipientEIN>941156365</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>730809</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>JUST BIOTHERAPEUTICS</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>401 TERRY AVE N</AddressLine1Txt>
          <CityNm>SEATTLE</CityNm>
          <StateAbbreviationCd>WA</StateAbbreviationCd>
          <ZIPCd>98109</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <CashGrantAmt>1000000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NEW YORK UNIVERSITY SCHOOL OF MEDICINE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>550 FIRST AVENUE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10016</ZIPCd>
        </USAddress>
        <RecipientEIN>135562309</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>100000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>HEALTH PARTNERS INSTITUTE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO BOX 1524</AddressLine1Txt>
          <CityNm>MINNEAPOLIS</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55440</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>373016</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>RTI INTERNATIONAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>RES TRIANGLE PK</AddressLine1Txt>
          <CityNm>RES TRIANGLE</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>27709</ZIPCd>
        </USAddress>
        <RecipientEIN>440680117</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>411375</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NEW YORK STEM CELL FOUNDATION</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>619 WEST 54TH STREET</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10019</ZIPCd>
        </USAddress>
        <RecipientEIN>202905531</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>200000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BECKMAN RESEARCH INST OF THE CITY OF HOPE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1500 EAST DUARTE ROAD</AddressLine1Txt>
          <CityNm>DUARTE</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>91010</ZIPCd>
        </USAddress>
        <RecipientEIN>953432210</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>1824293</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>OREGON HEALTH &amp; SCIENCE UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3181 SW SAM JACKSON</AddressLine1Txt>
          <CityNm>PORTLAND</CityNm>
          <StateAbbreviationCd>OR</StateAbbreviationCd>
          <ZIPCd>97239</ZIPCd>
        </USAddress>
        <RecipientEIN>237083114</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>500871</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>IBM</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1 N CASTLE DR</AddressLine1Txt>
          <CityNm>ARMONK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10504</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <CashGrantAmt>1360000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>PACIFIC DIABETES TECHNOLOGIES</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>12154 SW GARDEN PLACE</AddressLine1Txt>
          <CityNm>PORTLAND</CityNm>
          <StateAbbreviationCd>OR</StateAbbreviationCd>
          <ZIPCd>97223</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>220689</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF FLORIDA</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1600 SW ARCHER ROAD</AddressLine1Txt>
          <CityNm>GAINESVILLE</CityNm>
          <StateAbbreviationCd>FL</StateAbbreviationCd>
          <ZIPCd>32610</ZIPCd>
        </USAddress>
        <RecipientEIN>590974739</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>12209832</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>55 LAKE AVE NORTH</AddressLine1Txt>
          <CityNm>WORCESTER</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>01605</ZIPCd>
        </USAddress>
        <RecipientEIN>043167352</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>62640</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF MIAMI SCHOOL OF MEDICINE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1450 NW 10TH AVE</AddressLine1Txt>
          <CityNm>MIAMI</CityNm>
          <StateAbbreviationCd>FL</StateAbbreviationCd>
          <ZIPCd>33136</ZIPCd>
        </USAddress>
        <RecipientEIN>590624458</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>1770121</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF VIRGINIA</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>104 MIDMONT LN</AddressLine1Txt>
          <CityNm>CHARLOTTESVILLE</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>22902</ZIPCd>
        </USAddress>
        <RecipientEIN>416042488</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>212516</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF MICHIGAN</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>2003 S STATE STREET</AddressLine1Txt>
          <CityNm>ANN ARBOR</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>48109</ZIPCd>
        </USAddress>
        <RecipientEIN>386006309</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>625000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>LEK CONSULTING</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>75 STATE STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02109</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <CashGrantAmt>396250</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>LOCKHEED MARTIN</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>199 BORTON LANDING RD</AddressLine1Txt>
          <CityNm>MOORESTOWN</CityNm>
          <StateAbbreviationCd>NJ</StateAbbreviationCd>
          <ZIPCd>08057</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <CashGrantAmt>261908</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF CALIFORNIA</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3333 CA ST</AddressLine1Txt>
          <CityNm>SAN FRANCISCO</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>94122</ZIPCd>
        </USAddress>
        <RecipientEIN>956006143</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>2738857</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF WISCONSIN-MADISON</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1220 LINDEN DRIVE</AddressLine1Txt>
          <CityNm>MADISON</CityNm>
          <StateAbbreviationCd>WI</StateAbbreviationCd>
          <ZIPCd>53706</ZIPCd>
        </USAddress>
        <RecipientEIN>396006492</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>500000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UT SOUTHWESTERN MEDICAL CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>5323 HARRY HINES BLVD</AddressLine1Txt>
          <CityNm>DALLAS</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>75390</ZIPCd>
        </USAddress>
        <RecipientEIN>756002868</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>2045720</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>VANDERBILT UNIVERSITY MEDICAL CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1211 MEDICAL CENTER DR</AddressLine1Txt>
          <CityNm>NASHVILLE</CityNm>
          <StateAbbreviationCd>TN</StateAbbreviationCd>
          <ZIPCd>37232</ZIPCd>
        </USAddress>
        <RecipientEIN>620476822</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>278547</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>LOUISIANA STATE UNIV HEALTH SCIENCE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>433 BOLIVAR STREET</AddressLine1Txt>
          <CityNm>NEW ORLEANS</CityNm>
          <StateAbbreviationCd>LA</StateAbbreviationCd>
          <ZIPCd>70112</ZIPCd>
        </USAddress>
        <RecipientEIN>270158443</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>899171</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BAYLOR COLLEGE OF MEDICINE-RESEARCH INSTITUTE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>ONE BAYLOR PLAZA</AddressLine1Txt>
          <CityNm>HOUSTON</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>77030</ZIPCd>
        </USAddress>
        <RecipientEIN>751921898</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>180000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BROAD INSTITUTE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>415 MAIN STREET</AddressLine1Txt>
          <CityNm>CAMBRIDGE</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02142</ZIPCd>
        </USAddress>
        <RecipientEIN>263428781</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>253781</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NAT INST OF DIABETS &amp; DIGESTIVE DISEASES</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>6707 DEMOCRACY BLVD</AddressLine1Txt>
          <CityNm>BETHESDA</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>20892</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <CashGrantAmt>200000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF CONNECTICUT</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>69 N EAGLEVILLE</AddressLine1Txt>
          <CityNm>STORRS</CityNm>
          <StateAbbreviationCd>CT</StateAbbreviationCd>
          <ZIPCd>06269</ZIPCd>
        </USAddress>
        <RecipientEIN>066085975</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>249998</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF SOUTH FLORIDA</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>4202 E FOWLER AVE</AddressLine1Txt>
          <CityNm>TAMPA</CityNm>
          <StateAbbreviationCd>FL</StateAbbreviationCd>
          <ZIPCd>33620</ZIPCd>
        </USAddress>
        <RecipientEIN>590879015</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>426420</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>JAEB CENTER FOR HEALTH RESEARCH FND</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>15310 Amberly Drive</AddressLine1Txt>
          <CityNm>TAMPA</CityNm>
          <StateAbbreviationCd>FL</StateAbbreviationCd>
          <ZIPCd>33647</ZIPCd>
        </USAddress>
        <RecipientEIN>593187624</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>3692067</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>VIACYTE INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3550 GENERAL ATOMICS</AddressLine1Txt>
          <CityNm>SAN DIEGO</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>92121</ZIPCd>
        </USAddress>
        <RecipientEIN>330884172</RecipientEIN>
        <CashGrantAmt>2150000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>COLUMBIA UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>535 W 116TH ST</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10027</ZIPCd>
        </USAddress>
        <RecipientEIN>135598093</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>110000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>YALE UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO BOX 209010</AddressLine1Txt>
          <CityNm>NEW HAVEN</CityNm>
          <StateAbbreviationCd>CT</StateAbbreviationCd>
          <ZIPCd>06520</ZIPCd>
        </USAddress>
        <RecipientEIN>060646973</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>2113953</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>SFC FLUIDICS INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>534 WEST RES CENTER</AddressLine1Txt>
          <CityNm>FAYETTEVILLE</CityNm>
          <StateAbbreviationCd>AR</StateAbbreviationCd>
          <ZIPCd>72701</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <CashGrantAmt>200000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF ALABAMA AT BIRMINGHAM</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1720 2ND AVS S</AddressLine1Txt>
          <CityNm>BIRMINGHAM</CityNm>
          <StateAbbreviationCd>AL</StateAbbreviationCd>
          <ZIPCd>35294</ZIPCd>
        </USAddress>
        <RecipientEIN>636001138</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>175622</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>55 FRUIT STREET</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02114</ZIPCd>
        </USAddress>
        <RecipientEIN>042697983</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>486646</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NORTHWESTERN UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>633 CLARK STREET</AddressLine1Txt>
          <CityNm>EVANSTON</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60208</ZIPCd>
        </USAddress>
        <RecipientEIN>231352685</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>910280</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>ICAHN SCHOOL OF MEDICINE MOUNT SINAI</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1 GUSTAVE L LEVY PLACE</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10029</ZIPCd>
        </USAddress>
        <RecipientEIN>136171197</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>438716</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>NOVARTIS INSTITUTE-GENOMICS</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>10675 JOHN HOPKINS DR</AddressLine1Txt>
          <CityNm>SAN DIEGO</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>92121</ZIPCd>
        </USAddress>
        <RecipientEIN>223610512</RecipientEIN>
        <CashGrantAmt>2000000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>ILLINOIS INSTITUTE OF TECHNOLOGY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3300 SOUTH FEDERAL STREET</AddressLine1Txt>
          <CityNm>CHICAGO</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60616</ZIPCd>
        </USAddress>
        <RecipientEIN>362170136</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>250000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF MINNESOTA</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>200 OAK ST SE</AddressLine1Txt>
          <CityNm>MINNEAPOLIS</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55455</ZIPCd>
        </USAddress>
        <RecipientEIN>416007513</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>299999</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>JACKSON LABORATORY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>600 MAIN STREET</AddressLine1Txt>
          <CityNm>BAR HARBOR</CityNm>
          <StateAbbreviationCd>ME</StateAbbreviationCd>
          <ZIPCd>04609</ZIPCd>
        </USAddress>
        <RecipientEIN>010211513</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>312227</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>RUTGERS THE STATE UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>175 UNIVERSITY AVE</AddressLine1Txt>
          <CityNm>NEWARK</CityNm>
          <StateAbbreviationCd>NJ</StateAbbreviationCd>
          <ZIPCd>07107</ZIPCd>
        </USAddress>
        <RecipientEIN>462354111</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>439559</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF WASHINGTON</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>4333 BROOKLYN AVE NE</AddressLine1Txt>
          <CityNm>SEATTLE</CityNm>
          <StateAbbreviationCd>WA</StateAbbreviationCd>
          <ZIPCd>98195</ZIPCd>
        </USAddress>
        <RecipientEIN>911486484</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>161617</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>WESTERN MICHIGAN UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>300 PORTAGE STREET</AddressLine1Txt>
          <CityNm>KALAMAZOO</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>49007</ZIPCd>
        </USAddress>
        <RecipientEIN>454135256</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>125477</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>THE MEDICAL COLLEGE OF WISCONSIN</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>8701 W WATERTOWN</AddressLine1Txt>
          <CityNm>MILWAUKEE</CityNm>
          <StateAbbreviationCd>WI</StateAbbreviationCd>
          <ZIPCd>53226</ZIPCd>
        </USAddress>
        <RecipientEIN>611730890</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>324765</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>TIDEPOOL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>555 BRYANT</AddressLine1Txt>
          <CityNm>ST PALO ALTO</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>94301</ZIPCd>
        </USAddress>
        <RecipientEIN>462302287</RecipientEIN>
        <CashGrantAmt>664109</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>ARTIFICIAL PANCREAS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>THE METHODIST HOSPITAL RESEARCH INST</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>6670 BERTNER AVE</AddressLine1Txt>
          <CityNm>HOUSTON</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>77030</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>109821</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF UTAH</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>201 PRESIDENTS CR</AddressLine1Txt>
          <CityNm>SALT LAKE CITY</CityNm>
          <StateAbbreviationCd>UT</StateAbbreviationCd>
          <ZIPCd>84112</ZIPCd>
        </USAddress>
        <RecipientEIN>876000525</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>730746</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>GLUCOSE MODULATION</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>WAYNE STATE UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>42 W WARREN AVE</AddressLine1Txt>
          <CityNm>DETROIT</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>48202</ZIPCd>
        </USAddress>
        <RecipientEIN>383555142</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>385822</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>ENCAPSULATED ISLETS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>PROTOMER TECHNOLOGIES</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>530 SOUTH LAKE AVE</AddressLine1Txt>
          <CityNm>PASADENA</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>91101</ZIPCd>
        </USAddress>
        <RecipientEIN>474206994</RecipientEIN>
        <CashGrantAmt>270000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF SOUTHERN CALIFORNIA</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3720 S FLOWER STREET</AddressLine1Txt>
          <CityNm>LOS ANGELES</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>90089</ZIPCd>
        </USAddress>
        <RecipientEIN>951642394</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>166022</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF COLORADO</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1800 GRANT STREET</AddressLine1Txt>
          <CityNm>DENVER</CityNm>
          <StateAbbreviationCd>CO</StateAbbreviationCd>
          <ZIPCd>80203</ZIPCd>
        </USAddress>
        <RecipientEIN>846049811</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>4144193</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1 COLLEGE HALL</AddressLine1Txt>
          <CityNm>PHILADELPHIA</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>19104</ZIPCd>
        </USAddress>
        <RecipientEIN>231352685</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>110000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNITIO INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>11 AVENUE DE LAYFETTE</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02111</ZIPCd>
        </USAddress>
        <RecipientEIN>451623549</RecipientEIN>
        <CashGrantAmt>1250000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF MARYLAND BALTIMORE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>620 WEST LEXINGTON ST</AddressLine1Txt>
          <CityNm>BALTIMORE</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>21201</ZIPCd>
        </USAddress>
        <RecipientEIN>522004514</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>273718</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF TEXAS HEALTH SCIENCE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>7703 FLOYD CURL DRIVE</AddressLine1Txt>
          <CityNm>SAN ANTONIO</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>78229</ZIPCd>
        </USAddress>
        <RecipientEIN>741586031</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>890776</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>WASHINGTON UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>One Brookings Drive</AddressLine1Txt>
          <CityNm>St Louis</CityNm>
          <StateAbbreviationCd>MO</StateAbbreviationCd>
          <ZIPCd>63130</ZIPCd>
        </USAddress>
        <RecipientEIN>430653611</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>303340</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF KANSAS CENTER FOR RESEARCH</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>2385 IRVING HILL DR</AddressLine1Txt>
          <CityNm>LAWRENCE</CityNm>
          <StateAbbreviationCd>KS</StateAbbreviationCd>
          <ZIPCd>66045</ZIPCd>
        </USAddress>
        <RecipientEIN>480680117</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>249997</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>VTV THERAPEUTICS LLC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>4170 MENDENHALL OAKS</AddressLine1Txt>
          <CityNm>HIGH POINT</CityNm>
          <StateAbbreviationCd>NC</StateAbbreviationCd>
          <ZIPCd>27265</ZIPCd>
        </USAddress>
        <RecipientEIN>999999999</RecipientEIN>
        <CashGrantAmt>540000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BOSTON CHILDREN'S HOSPITAL</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>300 LONGWOOD AVENUE</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02115</ZIPCd>
        </USAddress>
        <RecipientEIN>043266103</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>572597</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>HARVARD COLLEGE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>677 HUNTINGTON AVE</AddressLine1Txt>
          <CityNm>BOSTON</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02115</ZIPCd>
        </USAddress>
        <RecipientEIN>042103580</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>617165</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>WILLIAM MARSH RICE UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>6100 MAIN STREET M16</AddressLine1Txt>
          <CityNm>HOUSTON</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>77005</ZIPCd>
        </USAddress>
        <RecipientEIN>741109620</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>150000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>DREXEL UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>2900 W QUEEN LANE</AddressLine1Txt>
          <CityNm>PHILADELPHIA</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>19104</ZIPCd>
        </USAddress>
        <RecipientEIN>231352630</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>150000</CashGrantAmt>
        <ValuationMethodUsedDesc>N/A</ValuationMethodUsedDesc>
        <NonCashAssistanceDesc>N/A</NonCashAssistanceDesc>
        <PurposeOfGrantTxt>IMMUNE THERAPIES</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>63</Total501c3OrgCnt>
      <TotalOtherOrgCnt>16</TotalOtherOrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>GRANT MONITORING PROCEDURES</FormAndLineReferenceDesc>
        <ExplanationTxt>SCH-I PART I LINE 2 Research grants are awarded by JDRF's Research Committee comprised of "JDRF Board members and other volunteers" following the recommendations of an in-house team of professional scientific staff and with input from external scientific reviewers and patient advocates. The review process includes the following criteria: (1) The scientific merit of the proposed research outlined in a grant application and (2) The relationship of the proposed research to JDRF's goal to cure, prevent and treat T1D and its complications. The scientific research team and grant administration staff maintain close contact with grantees, providing advice, evaluation, research progress reports, helping disseminate research results and reviewing research expenditures versus agreed budgets.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="IRS990ScheduleJ">
      <HousingAllowanceOrResidenceInd>X</HousingAllowanceOrResidenceInd>
      <WrittenPolicyRefTAndEExpnssInd>true</WrittenPolicyRefTAndEExpnssInd>
      <SubstantiationRequiredInd>false</SubstantiationRequiredInd>
      <CompensationCommitteeInd>X</CompensationCommitteeInd>
      <IndependentConsultantInd>X</IndependentConsultantInd>
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <WrittenEmploymentContractInd>X</WrittenEmploymentContractInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>true</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>false</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>false</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>false</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>true</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>DEREK RAPP</PersonNm>
        <TitleTxt>PRESIDENT AND CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>600000</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>150000</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>100000</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>12337</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>35123</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>897460</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>AARON KOWALSKI</PersonNm>
        <TitleTxt>CHIEF MISSION OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>381551</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>36540</BonusFilingOrganizationAmount>
        <DeferredCompensationFlngOrgAmt>7912</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>34240</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>460243</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>SANDRA HIJIKATA</PersonNm>
        <TitleTxt>CHIEF DEV OFFICER &amp; ASST. SECY</TitleTxt>
        <BaseCompensationFilingOrgAmt>375000</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>20000</BonusFilingOrganizationAmount>
        <DeferredCompensationFlngOrgAmt>12337</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>6011</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>413348</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>MARK GREENE</PersonNm>
        <TitleTxt>CFO &amp; ASST. TRES</TitleTxt>
        <BaseCompensationFilingOrgAmt>366250</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>31750</BonusFilingOrganizationAmount>
        <DeferredCompensationFlngOrgAmt>12337</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>13868</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>424205</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JILL CLARK</PersonNm>
        <TitleTxt>CHIEF OF STAFF &amp; ASST. SECY</TitleTxt>
        <BaseCompensationFilingOrgAmt>264833</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>24208</BonusFilingOrganizationAmount>
        <DeferredCompensationFlngOrgAmt>10828</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>6481</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>306350</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>STEVEN GRIFFEN MD</PersonNm>
        <TitleTxt>SVP RESEARCH</TitleTxt>
        <BaseCompensationFilingOrgAmt>115830</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>20000</BonusFilingOrganizationAmount>
        <OtherCompensationFilingOrgAmt>190600</OtherCompensationFilingOrgAmt>
        <DeferredCompensationFlngOrgAmt>12337</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>24327</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>363094</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JONATHAN R BEHR</PersonNm>
        <TitleTxt>MANAGING DIRECTOR JDRF-T1D FND</TitleTxt>
        <BaseCompensationFilingOrgAmt>302500</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>70000</BonusFilingOrganizationAmount>
        <DeferredCompensationFlngOrgAmt>12337</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>22424</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>407261</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>ALISA NORRIS</PersonNm>
        <TitleTxt>CHIEF MARKETING OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>353333</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>21422</BonusFilingOrganizationAmount>
        <DeferredCompensationFlngOrgAmt>12337</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>35085</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>422177</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JULIA GREENSTEIN</PersonNm>
        <TitleTxt>VP RESEARCH</TitleTxt>
        <BaseCompensationFilingOrgAmt>290323</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>25467</BonusFilingOrganizationAmount>
        <DeferredCompensationFlngOrgAmt>12337</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>2299</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>330426</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>SUSAN YUN</PersonNm>
        <TitleTxt>CHIEF PEOPLE OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>278334</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>25121</BonusFilingOrganizationAmount>
        <DeferredCompensationFlngOrgAmt>12337</DeferredCompensationFlngOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>7605</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>323397</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>HOUSING ALLOWANCE</FormAndLineReferenceDesc>
        <ExplanationTxt>SCHEDULE J PART I, LINE 1A Derek Rapp, Pres &amp; CEO, received a housing allowance as per the terms of his employment agreement. For the 2017 calendar year, the housing allowance provided to Derek Rapp was $75,000; such amount was treated as taxable compensation and included in his Form W-2. This amount was also reported on Schedule J, Part II, Col. (B) (III).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>OTHER REPORTABLE COMPENSATION</FormAndLineReferenceDesc>
        <ExplanationTxt>SCHEDULE J PART II, C (B)(iii) DEREK RAPP RECEIVED TRAVEL &amp; ALLOWANCE EXPENSES FOR THE 2017 CALENDAR YEAR, THE ALLOWANCE PROVIDED TO MR. RAPP WAS $25,000; SUCH AMOUNT WAS TREATED AS TAXABLE COMPENSATION AND INCLUDED IN HIS FORM W-2. THIS AMOUNT WAS ALSO REPORTED ON SCHEDULE J, PART II, COL (B)(iii).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>NON-FIXED PAYMENTS</FormAndLineReferenceDesc>
        <ExplanationTxt>FORM 990, SCHEDULE J, PART I, LINE 7 JDRF AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO THE EMPLOYEES PERFORMANCE. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2, PART II, COL. (B) (II).</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SEVERANCE PAYMENTS</FormAndLineReferenceDesc>
        <ExplanationTxt>SCHEDULE J, PART I, LINE 4A DR.STEVEN GRIFFEN RECEIVED A SEVERANCE PAYMENT OF $190,600 WHICH IS REPORTED ON SCHEDULE J, PART II, COL. (B)(III) OTHER REPORTABLE COMPENSATION.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="IRS990ScheduleL">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <PersonNm>ELIZABETH KECKLER</PersonNm>
        </NameOfInterested>
        <RelationshipDescriptionTxt>DAUGHTER OF ELLEN LEAKE</RelationshipDescriptionTxt>
        <TransactionAmt>60427</TransactionAmt>
        <TransactionDesc>EMPLOYMENT AT JDRF INT.</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>BUSINESS TRANSACTION</FormAndLineReferenceDesc>
        <ExplanationTxt>SCHEDULE L, PART IV, COLUMN B ELLEN LEAKE WAS THE BOARD VICE-CHAIR FOR YEAR END 6/30/2018 SCHEDULE L, PART IV, COLUMN C FOR EMPLOYEES LISTED, TOTAL COMPENSATION INCLUDES EMPLOYER PAID BENEFITS</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleL>
    <IRS990ScheduleM documentId="IRS990ScheduleM">
      <WorksOfArtGrp />
      <ArtHistoricalTreasuresGrp />
      <ArtFractionalInterestGrp />
      <BooksAndPublicationsGrp />
      <ClothingAndHouseholdGoodsGrp />
      <CarsAndOtherVehiclesGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>7</ContributionCnt>
        <NoncashContributionsRptF990Amt>225454</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>TICKET SALES</MethodOfDeterminingRevenuesTxt>
      </CarsAndOtherVehiclesGrp>
      <BoatsAndPlanesGrp />
      <IntellectualPropertyGrp />
      <SecuritiesPubliclyTradedGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <ContributionCnt>444</ContributionCnt>
        <NoncashContributionsRptF990Amt>7241869</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>NET PROCEEDS OF SALE</MethodOfDeterminingRevenuesTxt>
      </SecuritiesPubliclyTradedGrp>
      <SecuritiesCloselyHeldStockGrp />
      <SecurPrtnrshpTrustIntrstsGrp />
      <SecuritiesMiscellaneousGrp />
      <QualifiedContribHistStructGrp />
      <QualifiedContribOtherGrp />
      <RealEstateResidentialGrp />
      <RealEstateCommercialGrp />
      <RealEstateOtherGrp />
      <CollectiblesGrp />
      <FoodInventoryGrp />
      <DrugsAndMedicalSuppliesGrp />
      <TaxidermyGrp />
      <HistoricalArtifactsGrp />
      <ScientificSpecimensGrp />
      <ArchaeologicalArtifactsGrp />
      <OtherNonCashContriTableGrp>
        <NonCashCheckboxInd>X</NonCashCheckboxInd>
        <Desc>MISC AUCTION ITEMS DONATED</Desc>
        <ContributionCnt>27906</ContributionCnt>
        <NoncashContributionsRptF990Amt>12677494</NoncashContributionsRptF990Amt>
        <MethodOfDeterminingRevenuesTxt>FAIR MARKET VALUE</MethodOfDeterminingRevenuesTxt>
      </OtherNonCashContriTableGrp>
      <Form8283ReceivedCnt>3</Form8283ReceivedCnt>
      <AnyPropertyThatMustBeHeldInd>false</AnyPropertyThatMustBeHeldInd>
      <ReviewProcessUnusualNCGiftsInd>true</ReviewProcessUnusualNCGiftsInd>
      <ThirdPartiesUsedInd>true</ThirdPartiesUsedInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>THIRD PARTY ASSISTANCE</FormAndLineReferenceDesc>
        <ExplanationTxt>LINE 32B INSURANCE AUTO AUCTIONS LLC IS A THIRD PARTY CAR DONATION COMPANY THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CALL A TOLL FREE NUMBER AND THEY ARE PUT IN CONTACT WITH A TOWING SERVICE IN THEIR AREA. AFTER THE CAR IS DONATED, INSURANCE AUTO AUCTIONS HANDLES ALL IRS 1098-C REPORTING. INSURANCE AUTO AUCTIONS IS A LICENSED PROFESSIONAL FUNDRAISER AND IS LICENSED IN THE STATES THAT REQUIRE IT TO REGISTER. FOR THE PERIOD ENDING 6/30/18, THE CAR PROGRAM LLC RAISED $261,400 WITH TOTAL EXPENSES OF $107,183. A NET CHECK IS PAID DIRECTLY TO JDRF. JDRF DOES NOT PAY INSURANCE AUTO AUCTIONS ANY EXPENSES OR FEES DIRECTLY. TOTAL NET REVENUE FOR FY-18 WAS $154,217.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>NONCASH CONTRIBUTIONS</FormAndLineReferenceDesc>
        <ExplanationTxt>FORM 990, SCHEDULE M, PAGE 1 TYPES OF PROPERTY AND THE AMOUNTS LISTED IN PART I LINES 6, 9, and 25 ARE THE ACTUAL AMOUNT THAT DONORS HAVE DONATED FOR VEHICLES, SECURITIES, AND MISC ITEMS THAT ARE SOLD AT VARIOUS AUCTIONS &amp; RAFFLES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleM>
    <IRS990ScheduleO documentId="IRS990ScheduleO">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990- PART I, LINE 7B</FormAndLineReferenceDesc>
        <ExplanationTxt>INCLUDES 512(A)(7) AMOUNTS THAT ARE NOT REVENUE AND, THEREFORE, NOT REPORTED AS SUCH ON FORM 990.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PUBLIC DOCUMENTS</FormAndLineReferenceDesc>
        <ExplanationTxt>FORM 990, PAGE 6, PART VI, SECTION C, LINE 19 The organization makes its governing documents, conflict of interest policy and financial statements available to the public on its website: www.JDRF.org. The public may access copies of JDRF's W-9, annual reports, 990 tax returns, 501(c)(3) IRS letter, and audited financials, at the following link: www.jdrf.org/about/financials</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>EXECUTIVE COMPENSATION POLICY</FormAndLineReferenceDesc>
        <ExplanationTxt>PART VI, SECTION B, LINES 15a &amp; 15b JDRF's Board of Directors charges a Talent and Compensation Committee to develop and recommend a compensation philosophy that applies to all employees of JDRF, including recommendations regarding the compensation and benefits of JDRF senior management for approval by the Executive Committee. The Committee works in collaboration with the President and CEO and the Chief People Officer and other senior staff personnel in the JDRF Human Resources Department to ensure that 1) the Foundation's talent strategy supports and is aligned with its overall organization strategies; 2) JDRF is in compliance with IRS guidelines for determining reasonableness in pay practices; and 3) overall compensation for JDRF's key executives is competitive and aligned with pay philosophy. To attract and retain top scientific and executive talent to advance its mission, the organization pays competitive and appropriate salaries as determined by analysis of reliable data and input from independent third-party consultants. The review of JDRF executive compensation and benefits under the procedures noted above is completed annually by an independent Compensation Committee, and the basis for their determination IS documented contemporaneously in the minutes of the Committee's meetings, including most recently on June 20, 2018.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 REVIEW PROCESS</FormAndLineReferenceDesc>
        <ExplanationTxt>SECTION B, PART VI, QUESTION 11B JDRF has a rigorous standard approach to reviewing its 990. The Organization's Tax Manager works with its outside tax professionals to prepare the return and all supporting schedules. The draft return is reviewed by a number of individuals, including JDRF's Chief Financial Officer and Director of Accounting and Finance, the Chief Executive Officer, other executives, its external senior tax advisor and others as necessary to ensure accuracy. Any questions and changes with respect to the draft return are addressed. Following this process, the return is reviewed by JDRF's Audit Committee of the Board of Directors with its outside tax advisors. Once approved, the return is distributed to all members of JDRF's Board of Directors for review and comment before it is filed with the Internal Revenue Service.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 PART VI, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>BOARD MEMBERS DOUG LOWENSTEIN &amp; LARRY SOLER HAVE A BUSINESS RELATIONSHIP.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART III: STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS</FormAndLineReferenceDesc>
        <ExplanationTxt>LINE 4A ($84,651,980) RESEARCH GRANTS JDRF has played a significant role in nearly every T1D therapeutic advance of the past four decades. We have more than 500 active T1D research grants funded in the United States and 19 other countries around the world - more than 150 grants in 2018 alone. Additionally, seventy-five JDRF-funded clinical trials are currently under way. The full impact of JDRF's research investment extends well beyond direct funding. JDRF leverages partnerships with academia, industry and clinicians to accelerate the most promising research opportunities. Accomplished experts and leaders in the field of T1D science and medicine guide the organization's funding efforts in the United States and around the world. Our highest priority is developing a cure for T1D and its complications. As we increase our understanding of the causes of T1D, we will also uncover ways to prevent them from occurring. At the same time, we're focused on developing better therapies to help people with T1D live healthier lives today. The foundation's diversified research portfolio includes the following therapy areas: Artificial Pancreas: Artificial pancreas (AP) systems use technology to replicate the operation of a normal human pancreas and are one of the most revolutionary advances in diabetes care since the discovery of insulin. JDRF has been pivotal in developing and pursuing AP systems, and has transformed the field in less than 10 years by working closely with numerous partners, researchers and companies to overcome the challenges that had prevented AP technology from moving forward. Today, JDRF's Artificial Pancreas Program is working to advance next-generation technology that is small, user-friendly and accurate, so that people with T1D can get through the day without needing to check blood sugar levels or dose insulin as often. These systems link continuous glucose monitors and insulin pumps to smart software so that the right amount of insulin is delivered at the right time. Our advocacy efforts, for instance, helped shave years off the regulatory approval process for the first Artificial Pancreas system, now on the market. Beta Cell Regeneration: The JDRF Beta Cell Regeneration Program aims to find and develop treatments to maintain the health and function of insulin-producing beta cells - and to develop therapies to generate new ones. The creation of the Network for Pancreatic Organ Donors with Diabetes, or nPOD, a JDRF initiative, helped uncover the opportunities of beta cell regeneration. Beta Cell Replacement: The JDRF Beta Cell Replacement program focuses on creating and then placing new insulin-producing beta cells back in the body, potentially allowing people with T1D to live years, even decades, without glucose monitoring and insulin injections. Complications: Despite advances in glucose control, many people with T1D are still at risk of developing serious kidney, eye, heart and nerve diseases. JDRF's Complications Program focuses on eye and kidney diseases, two areas where we believe we will have the most impact. Glucose Control: Even with today's technology, maintaining tight glucose control can be challenging. Our Glucose Control Program is driving clinical trials and breakthrough solutions to make the management of glucose easier and to keep people with T1D healthier. Immunotherapies: In people with T1D, the immune system mistakes the body's own cells for dangerous invaders and targets the pancreas' insulin-producing beta cells. As a result of beta cell death, people with T1D depend on external insulin to survive. Our approach through JDRF's Immunotherapies Program is to disable overactive immune assassins, boost "good" cells that can control and inhibit the killer cells, and restore immune control. Prevention: The JDRF Prevention Program works to eliminate the threat of T1D from future generations - and translate research knowledge into therapies that can stop T1D from developing. Until we have found ways to prevent T1D, we must stop or slow its progression during its earliest stages. Our approach is to expand T1D screening, delay the onset of T1D, and develop a vaccine. For more information on these scientific initiatives, visit jdrf.org/research. The JDRF T1D Fund (www.t1dfund.org), a wholly owned subsidiary of JDRF, is a venture philanthropy fund accelerating life-changing solutions to treat, prevent and cure T1D through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, pharma and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, devices, diagnostics, and vaccines to help people living with T1D or at risk of developing the disease. The T1D Fund invests in opportunities that drive our mission, with an exclusive focus on the best commercial opportunities. All funds go directly to support companies developing approaches to treat, prevent and cure T1D. In accordance with GAAP, $11.3MM of the T1D Fund's total investments as of June 30, 2018 are reflected in the Balance Sheet (Part X) and not included within the organization's research-related mission expense. LINE 4B ($23,138,667) RESEARCH SUPPORT JDRF's in-house team of skilled and credentialed scientific, policy and government relations professionals play critical roles in leading and supporting the research strategy and distribution of research funds from JDRF - and our partner organizations - to create a world without T1D. Our professionals identify, evaluate and influence groundbreaking research funded by JDRF, other foundations, governments and industry to accelerate the mission we all share. JDRF professionals work with regulatory and policy officials to ensure research can proceed without delay and that research results are well understood by healthcare decision makers. As part of these efforts, JDRF organizes and funds scientific meetings, symposia, and conferences to review research proposals, ensure that JDRF's research strategy is aligned with the needs of the T1D community, and allow JDRF to provide scientific updates on the research it manages. This effort ensures that all the research is continually shared and built upon by T1D researchers around the globe. JDRF's external Research Advisory Committee (RAC) is composed of professionals who are internationally renowned for their expertise in research as well as the care and treatment of people with T1D. The RAC advises on matters of policy related to research philosophy and procedures. JDRF's work to bring together the best minds in the field enhances JDRF's ability to forecast future scientific direction, judge the potential effectiveness of new pathways, and identify gaps where JDRF funding can make the most impact. LINE 4C ($56,284,982) PUBLIC EDUCATION JDRF is uniquely qualified to provide public education about diabetes and its complications. JDRF's efforts impact not only the millions of people living with T1D, their families and the general public, but also those at risk for developing the disease. T1D strikes both children and adults suddenly, and the adjustment period following a diagnosis can be overwhelming. That's why we support families navigating this challenging time. JDRF also educates people about the warning signs of T1D, which can be profoundly helpful in ensuring timely diagnoses and reducing the potential catastrophic consequences of undiagnosed T1D. JDRF also provides information and updates about current research directions and progress and about human clinical trials that are seeking participants (including through JDRF's Clinical Trials Connection matching tool: www.jdrf.org/research/clinical-trials). Through all of our 70 U.S. chapters, six international affiliates in Australia, Canada, Denmark, Israel, the Netherlands and United Kingdom - and our 30,000 members of our social network, TypeOneNation - JDRF supports the T1D community's diverse needs, connecting people with local support, expert resources, and the global effort to create a world without T1D.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>CONFLICT OF INTEREST POLICY</FormAndLineReferenceDesc>
        <ExplanationTxt>FORM 990- PART VI-SECT B, LINE 12C All officers, directors, key employees, board and committee members (both chapters and international boards) are required to sign a conflict of interest policy annually and disclose any conflicts. The Office of the President and CEO manages this process, and JDRF's internal audit department annually audits to ensure compliance. If any conflict does arise, the board members with the conflicts will recuse themselves from the meeting and/or vote.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="IRS990ScheduleR">
      <IdDisregardedEntitiesGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>JDRF T1D FUND LLC</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>C/O JDRF - 26 BROADWAY 14TH FLOOR</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10004</ZIPCd>
        </USAddress>
        <EIN>274967989</EIN>
        <PrimaryActivitiesTxt>FUNDR/INVEST</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>DE</LegalDomicileStateCd>
        <TotalIncomeAmt>15400127</TotalIncomeAmt>
        <EndOfYearAssetsAmt>45466963</EndOfYearAssetsAmt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>JDRF</BusinessNameLine1Txt>
        </DirectControllingEntityName>
      </IdDisregardedEntitiesGrp>
      <IdRelatedOrgTxblCorpTrGrp>
        <RelatedOrganizationName>
          <BusinessNameLine1Txt>CHARITABLE REMAINDER TRUST (5)</BusinessNameLine1Txt>
        </RelatedOrganizationName>
        <PrimaryActivitiesTxt>ANNUITY</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>PA</LegalDomicileStateCd>
        <ControlledOrganizationInd>true</ControlledOrganizationInd>
      </IdRelatedOrgTxblCorpTrGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>false</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>false</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>false</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>false</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>false</LoansOrGuaranteesFromOthOrgInd>
      <AssetSaleToOtherOrgInd>false</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>false</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>false</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>false</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>false</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>false</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>false</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>false</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>false</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>false</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>false</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>false</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>false</TransferFromOtherOrgInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE R, PART I, LINE (1B)</FormAndLineReferenceDesc>
        <ExplanationTxt>THE PRIMARY ACTIVITY FOR THE JDRF T1D FUND IS FUNDRAISING AND INVESTING IN TYPE ONE DIABETES RESEARCH. PLEASE SEE DETAILED DESCRIPTION ON SCHEDULE O, PART III, LINE 4A, STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS FOR RESEARCH GRANTS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleR>
  </ReturnData>
</Return>